Osaic Holdings
APYX icon

Osaic Holdings’s Apyx Medical APYX Stock Holding History

Osaic Holdings’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.9K Sell
12,000
-2,400
-17% -$9.52K ﹤0.01% 5422
2026
Q1 		$53.1K Buy
14,400
+6,000
+71% +$22.4K ﹤0.01% 5166
2025
Q4 		$29.4K Buy
8,400
+900
+12% +$3.14K ﹤0.01% 5599
2025
Q3 		$16.4K Sell
7,500
-14,700
-66% -$31.1K ﹤0.01% 6064
2025
Q2 		$50K Buy
+22,200
New +$31.3K ﹤0.01% 5056
2024
Q3 		– Sell
-6,200
Closed -$8.31K – 7399
2024
Q2 		$8.31K Buy
6,200
+3,700
+148% +$5.46K ﹤0.01% 5894
2024
Q1 		$3.4K Sell
2,500
-8,776
-78% -$18.7K ﹤0.01% 6257
2023
Q4 		$29.5K Buy
11,276
+2,901
+35% +$7.02K ﹤0.01% 5258
2023
Q3 		$26.8K Sell
8,375
-10,235
-55% -$47.7K ﹤0.01% 5390
2023
Q2 		$93.6K Buy
18,610
+3
+0% +$15 ﹤0.01% 4488
2023
Q1 		$53.6K Sell
18,607
-987
-5% -$2.88K ﹤0.01% 4898
2022
Q4 		$46K Buy
19,594
+9,498
+94% +$29K ﹤0.01% 5001
2022
Q3 		$45K Sell
10,096
-3,596
-26% -$25.8K ﹤0.01% 4989
2022
Q2 		$81K Buy
13,692
+8,926
+187% +$45.8K ﹤0.01% 4579
2022
Q1 		$32K Buy
4,766
+1,903
+66% +$18.7K ﹤0.01% 5395
2021
Q4 		$37K Buy
2,863
+854
+43% +$11.9K ﹤0.01% 5362
2021
Q3 		$28K Sell
2,009
-181
-8% -$1.9K ﹤0.01% 5527
2021
Q2 		$23K Buy
2,190
+719
+49% +$7.12K ﹤0.01% 5562
2021
Q1 		$14K Buy
1,471
+866
+143% +$8.66K ﹤0.01% 5690
2020
Q4 		$4K Buy
605
+310
+105% +$2.06K ﹤0.01% 5824
2020
Q3 		$1K Buy
295
+195
+195% +$966 ﹤0.01% 5962
2020
Q2 		$1K Buy
+100
New +$416 ﹤0.01% 5890

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings's APYX Position: Q2 2026 in Review

Osaic Holdings reduced its Apyx Medical (APYX) stake by 17% in Q2 2026, selling an estimated $9.52K and leaving 12,000 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5422.

Osaic Holdings first reported a position in APYX in Q2 2020 and has held it in 22 quarters since. The position peaked at $93.6K in Q2 2023. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Osaic Holdings held 12,000 shares of Apyx Medical worth $53.9K as of Q2 2026.
  • Osaic Holdings sold 2,400 Apyx Medical shares in Q2 2026, an estimated $9.52K.
  • Apyx Medical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5422 holding.
  • Osaic Holdings first reported a position in Apyx Medical in Q2 2020 and has held it in 22 quarters since.
  • Osaic Holdings's Apyx Medical position peaked at $93.6K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.